{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T14:16:10Z","timestamp":1784211370489,"version":"3.55.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARF-17-529092"],"award-info":[{"award-number":["AARF-17-529092"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["EFOP-3.6.1-16-2016-00022"],"award-info":[{"award-number":["EFOP-3.6.1-16-2016-00022"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["K119417"],"award-info":[{"award-number":["K119417"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["AARF-17-529092"],"award-info":[{"award-number":["AARF-17-529092"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["EFOP-3.6.1-16-2016-00022"],"award-info":[{"award-number":["EFOP-3.6.1-16-2016-00022"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003549","name":"Hungarian Scientific Research Fund","doi-asserted-by":"publisher","award":["K119417"],"award-info":[{"award-number":["K119417"]}],"id":[{"id":"10.13039\/501100003549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["AARF-17-529092"],"award-info":[{"award-number":["AARF-17-529092"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["EFOP-3.6.1-16-2016-00022"],"award-info":[{"award-number":["EFOP-3.6.1-16-2016-00022"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["GINOP-2.3.2-15-2016-00015"],"award-info":[{"award-number":["GINOP-2.3.2-15-2016-00015"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","award":["K119417"],"award-info":[{"award-number":["K119417"]}],"id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicon"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.toxicon.2021.03.002","type":"journal-article","created":{"date-parts":[[2021,3,6]],"date-time":"2021-03-06T18:12:41Z","timestamp":1615054361000},"page":"29-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Lipopolysaccharide influences the plasma and brain pharmacokinetics of subcutaneously-administered HsTX1[R14A], a KV1.3-blocking peptide"],"prefix":"10.1016","volume":"195","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0550-1683","authenticated-orcid":false,"given":"Sanjeevini Babu","family":"Reddiar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1695-3300","authenticated-orcid":false,"given":"Liang","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3871-9980","authenticated-orcid":false,"given":"Dorothy C.C.","family":"Wai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agota","family":"Csoti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gyorgy","family":"Panyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8893-0584","authenticated-orcid":false,"given":"Raymond S.","family":"Norton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph A.","family":"Nicolazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxicon.2021.03.002_bib1","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1124\/mol.104.007187","article-title":"Anuroctoxin, a new scorpion toxin of the \u03b1-KTx 6 subfamily, is highly selective for Kv1.3 over IKCa1 ion channels of human T lymphocytes","volume":"67","author":"Bagdany","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2021.03.002_bib2","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1186\/1471-2377-9-S1-S3","article-title":"Characteristics of compounds that cross the blood-brain barrier","volume":"9","author":"Banks","year":"2009","journal-title":"BMC Neurol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib3","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1210\/en.2007-1091","article-title":"Nitric oxide isoenzymes regulate lipopolysaccharide-enhanced insulin transport across the blood-brain barrier","volume":"149","author":"Banks","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.toxicon.2021.03.002_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12974-015-0434-1","article-title":"Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit","volume":"12","author":"Banks","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.toxicon.2021.03.002_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.bbi.2009.09.001","article-title":"Minimal penetration of lipopolysaccharide across the murine blood-brain barrier","volume":"24","author":"Banks","year":"2010","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.toxicon.2021.03.002_bib6","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1038\/s41598-017-03998-x","article-title":"Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats","volume":"7","author":"Bergmann","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2021.03.002_bib7","doi-asserted-by":"crossref","first-page":"271359","DOI":"10.1155\/2013\/271359","article-title":"Systemic immune activation leads to neuroinflammation and sickness behavior in mice","volume":"2013","author":"Biesmans","year":"2013","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.toxicon.2021.03.002_bib8","first-page":"603","article-title":"Characterization of a potassium channel toxin from the Caribbean Sea anemone Stichodactyla helianthus","volume":"33","author":"Castaneda","year":"1995","journal-title":"Toxicon 1995"},{"key":"10.1016\/j.toxicon.2021.03.002_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cbpa.2017.02.015","article-title":"Peptide blockers of Kv1.3 channels in T cells as therapeutics for autoimmune disease","volume":"38","author":"Chandy","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib10","first-page":"529","article-title":"Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases","volume":"59","author":"Chi","year":"2012","journal-title":"Toxicon 2012"},{"key":"10.1016\/j.toxicon.2021.03.002_bib11","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.bbi.2011.06.006","article-title":"Cytokine and chemokine responses in serum and brain after single and repeated injections of lipopolysaccharide: multiplex quantification with path analysis","volume":"25","author":"Erickson","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.toxicon.2021.03.002_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev-immunol-032414-112212","article-title":"Ion channels in innate and adaptive immunity","volume":"33","author":"Feske","year":"2015","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib13","article-title":"The pharmacokinetic-pharmacodynamic model of azithromycin for lipopolysaccharide-induced depressive-like behavior in mice","volume":"8","author":"Hao","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.toxicon.2021.03.002_bib14","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib15","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nrn3880","article-title":"Immune attack: the role of inflammation in Alzheimer disease","volume":"16","author":"Heppner","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"issue":"Suppl. 1","key":"10.1016\/j.toxicon.2021.03.002_bib16","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.1016\/S1353-8020(11)70065-7","article-title":"Neuroinflammation in Parkinson's disease","volume":"18","author":"Hirsch","year":"2012","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.toxicon.2021.03.002_bib17","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF01854895","article-title":"Endotoxin-induced acute renal failure in mice. Effects of indomethacin and the thromboxane-synthetase antagonist UK 38.485","volume":"185","author":"Hirschberg","year":"1985","journal-title":"Res. Exp. Med."},{"key":"10.1016\/j.toxicon.2021.03.002_bib18","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1128\/AAC.01497-13","article-title":"Impact of lipopolysaccharide-induced inflammation on the disposition of the aminocephalosporin cefadroxil","volume":"57","author":"Huh","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxicon.2021.03.002_bib19","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.xphs.2016.05.008","article-title":"Enabling noninvasive systemic delivery of the Kv1.3-blocking peptide HsTX1[R14A] via the buccal mucosa","volume":"105","author":"Jin","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2021.03.002_bib20","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1128\/AAC.00765-13","article-title":"Species-Dependent blood-brain barrier disruption of lipopolysaccharide: amelioration by colistin in vitro and in vivo","volume":"57","author":"Jin","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.toxicon.2021.03.002_bib21","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.xphs.2015.10.025","article-title":"Pulmonary delivery of the Kv1.3-blocking peptide HsTX1[R14A] for the treatment of autoimmune diseases","volume":"105","author":"Jin","year":"2016","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.toxicon.2021.03.002_bib22","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1248\/bpb.31.1221","article-title":"Changes in digoxin pharmacokinetics treated with lipopolysaccharide in Wistar rats","volume":"31","author":"Kato","year":"2008","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.toxicon.2021.03.002_bib23","doi-asserted-by":"crossref","first-page":"12623","DOI":"10.1074\/jbc.M113.517037","article-title":"Blocking Kv1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma","volume":"289","author":"Koshy","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"Pt 1","key":"10.1016\/j.toxicon.2021.03.002_bib24","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/bj3280321","article-title":"A four-disulphide-bridged toxin, with high affinity towards voltage-gated K+ channels, isolated from Heterometrus spinnifer (Scorpionidae) venom","volume":"328","author":"Lebrun","year":"1997","journal-title":"Biochem. J."},{"key":"10.1016\/j.toxicon.2021.03.002_bib25","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/brain\/awx346","article-title":"Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept","volume":"141","author":"Maezawa","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.toxicon.2021.03.002_bib26","series-title":"Structure-Activity Relationships and Lipidation of a Potent and Selective Kv1.3 Inhibitor","author":"Mitchell","year":"2019"},{"key":"10.1016\/j.toxicon.2021.03.002_bib27","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.2042-7158.1993.tb05638.x","article-title":"Influence of a bacterial lipopolysaccharide on the pharmacokinetics of tobramycin in rats","volume":"45","author":"Nadai","year":"1993","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib28","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.neuint.2010.07.002","article-title":"Expression and regulation of toll-like receptors in cerebral endothelial cells","volume":"57","author":"Nagyoszi","year":"2010","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.toxicon.2021.03.002_bib29","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","article-title":"Microglia development and function","volume":"32","author":"Nayak","year":"2014","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib30","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/glia.23078","article-title":"Differential Kv1.3, KCa3.1, and Kir 2.1 expression in \"classically\" and \"alternatively\" activated microglia","volume":"65","author":"Nguyen","year":"2017","journal-title":"Glia"},{"key":"10.1016\/j.toxicon.2021.03.002_bib31","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/j.1440-1681.2010.05362.x","article-title":"Brain uptake of diazepam and phenytoin in a genetic animal model of absence epilepsy","volume":"37","author":"Nicolazzo","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/17460441.2017.1317243","article-title":"Enhancing the therapeutic potential of peptide toxins","volume":"6","author":"Norton","year":"2017","journal-title":"Expet Opin. Drug Discov."},{"key":"10.1016\/j.toxicon.2021.03.002_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2018.04.009","article-title":"Impact of aging, Alzheimer's disease and Parkinson's disease on the blood-brain barrier transport of therapeutics","volume":"135","author":"Pan","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.toxicon.2021.03.002_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40263-016-0405-9","article-title":"Crossing the blood-brain barrier: recent advances in drug delivery to the brain","volume":"31","author":"Patel","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.toxicon.2021.03.002_bib35","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1093\/neuonc\/not221","article-title":"Blockade of Kv1.3 channels ameliorates radiation-induced brain injury","volume":"16","author":"Peng","year":"2014","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib36","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1124\/mol.108.052704","article-title":"Engineering a stable and selective peptide blocker of the Kv1.3 channel in T lymphocytes","volume":"75","author":"Pennington","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib37","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3390\/md13010529","article-title":"Development of highly selective Kv1.3-blocking peptides based on the sea anemone peptide ShK","volume":"13","author":"Pennington","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.toxicon.2021.03.002_bib38","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.1016\/j.febslet.2012.09.038","article-title":"A C-terminally amidated analogue of ShK is a potent and selective blocker of the voltage-gated potassium channel Kv1.3","volume":"586","author":"Pennington","year":"2012","journal-title":"FEBS Lett."},{"key":"10.1016\/j.toxicon.2021.03.002_bib39","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/jvp.12244","article-title":"The acute phase response induced by Escherichia coli lipopolysaccharide modifies the pharmacokinetics and metabolism of florfenicol in rabbits","volume":"39","author":"Perez","year":"2016","journal-title":"J. Vet. Pharmacol. Therapeut."},{"key":"10.1016\/j.toxicon.2021.03.002_bib40","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/glia.20467","article-title":"Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration","volume":"55","author":"Qin","year":"2007","journal-title":"Glia"},{"key":"10.1016\/j.toxicon.2021.03.002_bib41","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-018-0254-8","article-title":"Identification and therapeutic modulation of a pro-inflammatory subset of disease-associated-microglia in Alzheimer's disease","volume":"13","author":"Rangaraju","year":"2018","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.toxicon.2021.03.002_bib42","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3233\/JAD-141704","article-title":"Potassium channel Kv1.3 is highly expressed by microglia in human Alzheimer's disease","volume":"44","author":"Rangaraju","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.toxicon.2021.03.002_bib43","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-017-0906-6","article-title":"A systems pharmacology-based approach to identify novel Kv1.3 channel-dependent mechanisms in microglial activation","volume":"14","author":"Rangaraju","year":"2017","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.toxicon.2021.03.002_bib44","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1038\/srep04509","article-title":"A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases","volume":"4","author":"Rashid","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.toxicon.2021.03.002_bib45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0304-3940(93)90927-D","article-title":"Bacterial collagenase disrupts extracellular matrix and opens blood-brain barrier in rat","volume":"160","author":"Rosenberg","year":"1993","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.toxicon.2021.03.002_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/s11481-008-9138-y","article-title":"Lipopolysaccharide impairs blood-brain barrier P-glycoprotein function in mice through prostaglandin- and nitric oxide-independent pathways","volume":"4","author":"Salkeni","year":"2009","journal-title":"J. Neuroimmune Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib47","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/nm.4397","article-title":"Microglia emerge as central players in brain disease","volume":"23","author":"Salter","year":"2017","journal-title":"Nat. Med."},{"key":"10.1016\/j.toxicon.2021.03.002_bib48","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1021\/acs.accounts.7b00204","article-title":"Jumping hurdles: peptides able to overcome biological barriers","volume":"50","author":"Sanchez-Navarro","year":"2017","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.toxicon.2021.03.002_bib49","first-page":"4195","article-title":"Kv1.3 modulates neuroinflammation and neurodegeneration in Parkinson's disease","volume":"130","author":"Sarkar","year":"2020","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.toxicon.2021.03.002_bib50","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1002\/jcp.22675","article-title":"Amyloid-\u03b2-induced reactive oxygen species production and priming are differentially regulated by ion channels in microglia","volume":"226","author":"Schilling","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib51","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1681\/ASN.2006050454","article-title":"Regulation of renal sodium transporters during severe inflammation","volume":"18","author":"Schmidt","year":"2007","journal-title":"J. Am. Soc. Nephrol. : JASN (J. Am. Soc. Nephrol.)"},{"key":"10.1016\/j.toxicon.2021.03.002_bib52","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib53","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ki.2012.62","article-title":"Acute endotoxemia in mice induces downregulation of megalin and cubilin in the kidney","volume":"82","author":"Schreiber","year":"2012","journal-title":"Kidney Int."},{"key":"10.1016\/j.toxicon.2021.03.002_bib54","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1172\/JCI117582","article-title":"Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated drug metabolism","volume":"94","author":"Shedlofsky","year":"1994","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.toxicon.2021.03.002_bib55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2174\/157015908785777210","article-title":"Brain endothelial cell-cell junctions: how to \"open\" the blood brain barrier","volume":"6","author":"Stamatovic","year":"2008","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib56","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/imm.12922","article-title":"Inflammation in CNS neurodegenerative diseases","volume":"154","author":"Stephenson","year":"2018","journal-title":"Immunol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib57","doi-asserted-by":"crossref","first-page":"114146","DOI":"10.1016\/j.bcp.2020.114146","article-title":"The voltage-gated potassium channel KV1.3 as a therapeutic target for venom-derived peptides","volume":"181","author":"Tajti","year":"2020","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib58","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.clim.2017.03.014","article-title":"Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog","volume":"180","author":"Tanner","year":"2017","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib59","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.112.191890","article-title":"Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease","volume":"342","author":"Tarcha","year":"2012","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.toxicon.2021.03.002_bib60","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejphar.2005.01.025","article-title":"Endotoxin from various gram-negative bacteria has differential effects on function of hepatic cytochrome P450 and drug transporters","volume":"510","author":"Ueyama","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2016.03.010","article-title":"The blood-brain barrier in systemic inflammation","volume":"60","author":"Varatharaj","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.toxicon.2021.03.002_bib62","doi-asserted-by":"crossref","first-page":"F571","DOI":"10.1152\/ajprenal.00538.2007","article-title":"Endotoxemia-related acute kidney injury in transgenic mice with endothelial overexpression of GTP cyclohydrolase-1","volume":"294","author":"Wang","year":"2008","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.toxicon.2021.03.002_bib63","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3389\/fnins.2019.01393","article-title":"Kv1.3 channel as a Key therapeutic target for neuroinflammatory diseases: state of the art and beyond","volume":"13","author":"Wang","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.toxicon.2021.03.002_bib64","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00211777","article-title":"1H, 13C and 15N chemical shift referencing in biomolecular NMR","volume":"6","author":"Wishart","year":"1995","journal-title":"J. Biomol. NMR"}],"container-title":["Toxicon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041010121000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:17:53Z","timestamp":1758575873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041010121000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":64,"alternative-id":["S0041010121000751"],"URL":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.03.002","relation":{},"ISSN":["0041-0101"],"issn-type":[{"value":"0041-0101","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipopolysaccharide influences the plasma and brain pharmacokinetics of subcutaneously-administered HsTX1[R14A], a KV1.3-blocking peptide","name":"articletitle","label":"Article Title"},{"value":"Toxicon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxicon.2021.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}